IDEXX LABORATORIES INC /DE Other Comprehensive Income (Loss), Net of Tax (Deprecated 2012-01-31)
IDEXX LABORATORIES INC /DE (IDXX) reported Other Comprehensive Income (Loss), Net of Tax (Deprecated 2012-01-31) of $4.04 million for the 3-month period ending 2012-03-31, per its 10-Q filed 2012-04-20.
Discontinued › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecrease · last filed 2012-04-20
- IDEXX LABORATORIES INC /DE other comprehensive income (loss), net of tax (deprecated 2012-01-31) for the quarter ending 2012-03-31 was $4.04M, a 34.02% decline year-over-year.
- IDEXX LABORATORIES INC /DE other comprehensive income (loss), net of tax (deprecated 2012-01-31) for the quarter ending 2011-03-31 was $6.12M.
| Period end | Other Comprehensive Income (Loss), Net of Tax (Deprecated 2012-01-31) 3 month |
|---|---|
| 2012-03-31 | $4.04M 10-Q · filed 2012-04-20 |
| 2011-03-31 | $6.12M 10-Q · filed 2012-04-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lantheus Holdings, Inc. (LNTH) | United States | $6.510B | 26.31 |
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |